Accuray Incorporated Company Profile (NASDAQ:ARAY)

About Accuray Incorporated (NASDAQ:ARAY)

Accuray Incorporated logoAccuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:ARAY
  • CUSIP: 00439710
  • Web: www.accuray.com
Capitalization:
  • Market Cap: $376.86 million
  • Outstanding Shares: 83,179,000
Average Prices:
  • 50 Day Moving Avg: $4.15
  • 200 Day Moving Avg: $4.43
  • 52 Week Range: $3.60 - $6.39
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -90.00
  • P/E Growth: 0.09
Sales & Book Value:
  • Annual Revenue: $383.41 million
  • Price / Sales: 0.98
  • Book Value: $0.56 per share
  • Price / Book: 8.04
Profitability:
  • EBIDTA: $640,996.00
  • Net Margins: -7.71%
  • Return on Equity: -61.62%
  • Return on Assets: -7.12%
Debt:
  • Debt-to-Equity Ratio: 1.11%
  • Current Ratio: 1.09%
  • Quick Ratio: 0.72%
Misc:
  • Average Volume: 472,575 shs.
  • Beta: 1.27
  • Short Ratio: 11.88
 

Frequently Asked Questions for Accuray Incorporated (NASDAQ:ARAY)

What is Accuray Incorporated's stock symbol?

Accuray Incorporated trades on the NASDAQ under the ticker symbol "ARAY."

How were Accuray Incorporated's earnings last quarter?

Accuray Incorporated (NASDAQ:ARAY) issued its quarterly earnings data on Tuesday, August, 22nd. The company reported ($0.06) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.05. The business earned $112.09 million during the quarter, compared to analysts' expectations of $112 million. Accuray Incorporated had a negative return on equity of 61.62% and a negative net margin of 7.71%. The business's quarterly revenue was up 18.0% on a year-over-year basis. During the same period in the previous year, the business earned ($0.09) earnings per share. View Accuray Incorporated's Earnings History.

When will Accuray Incorporated make its next earnings announcement?

Accuray Incorporated is scheduled to release their next quarterly earnings announcement on Thursday, October, 26th 2017. View Earnings Estimates for Accuray Incorporated.

Where is Accuray Incorporated's stock going? Where will Accuray Incorporated's stock price be in 2017?

5 brokerages have issued 1-year price objectives for Accuray Incorporated's stock. Their predictions range from $5.00 to $7.00. On average, they anticipate Accuray Incorporated's share price to reach $6.00 in the next twelve months. View Analyst Ratings for Accuray Incorporated.

What are analysts saying about Accuray Incorporated stock?

Here are some recent quotes from research analysts about Accuray Incorporated stock:

  • 1. According to Zacks Investment Research, "Over the past year, Accuray has underperformed the broader industry with respect to price. Accuray reported wider-than-expected loss in the fourth quarter of fiscal 2017, primarily due to lackluster performance in the service revenue segment. The company issued solid fiscal 2018 guidance. Of the recent developments, orders for the latest Radixact System, solid revenue performance in APAC and Japanese regulatory approval for Radixact are key positives in our view. However, unfavorable product mix, declining service revenues, sluggish macro economic conditions and pricing headwinds are major concerns. Notably, China and Europe saw sluggish revenues in the fourth quarter. Accuray’s significant international presence helps broaden its customer base. However, fluctuations in currency exchange rates, particularly with a strong dollar, will continue to adversely impact the company’s backlog and top line." (9/19/2017)
  • 2. BTIG Research analysts commented, "Results: In-Line Revenue with Soft Net Orders; Neutral ARAY’s results the past few years seem to reflect a company hampered by its positioning with low market share, missed guidance, delays by the Chinese government and a tough capital structure that is trying to do all that it can to reaccelerate growth. Our concern is that continued single digit growth with lumpy orders and some quarterly revenue misses just doesn’t excite investors and we are not sure what will accelerate growth meaningfully. We applaud new product innovation and focus on consistent results. With guidance reset earlier in the year, ARAY reported in-line rev but the conversion from orders has taken longer than expected with some geographic softness. ARAY is attempting to increase growth through multiple new products such as Radixact, OnRad, Precision Treatment Planning, and iDMS Data Management. We believe this may help but at the end of the day past execution keeps us at Neutral. FY18 guidance calls for revenue of $390M – $400M (2% – 4%) and gross order growth of 5%. Both seem reasonable but also not layups. We will continue to watch for more consistency and stronger growth that would bring investors back into the story." (8/24/2017)
  • 3. Aegis analysts commented, "The company has been successful in shifting gears to the smaller vault centers, re-positioning TomoTherapy as a work horse machine. Accuray has moved outside of the niche high-end large academic centers into the broader single- and dual-vault centers, with single- and dual-vault centers now accounting for 50% of new TomoTherapy orders (up from 0% in 2012).He added, "Radixact, the next-generation TomoTherapy platform, was approved for 510k in June (CE Mark in Aug) and brings ARAY up to par with Varian's TrueBeam and Elekta's Axesse machines. Radixact adds higher output dosing along with integrated treatment planning (Precision') and data management (iDMS') systems that will increase the ease and speed of systems, and should have its full launch in time for ARAYs first major replacement cycle. The reliability issues previously associated with TomoTherapy are now behind them, and Tomo is consistantly ranked #1 in overall system performance by ServiceTrak." (2/6/2017)

Who are some of Accuray Incorporated's key competitors?

Who are Accuray Incorporated's key executives?

Accuray Incorporated's management team includes the folowing people:

  • Louis J. Lavigne Jr., Independent Chairperson of the Board
  • Joshua H. Levine, President, Chief Executive Officer, Director
  • Elizabeth H. Davila, Independent Vice Chairperson of the Board
  • Kevin Waters, Chief Financial Officer, Senior Vice President
  • Alaleh Nouri, Senior Vice President, General Counsel, Corporate Secretary
  • Lionel Hadjadjeba, Senior Vice President, Chief Commercial Officer
  • Jack Goldstein Ph.D., Independent Director
  • Richard R. Pettingill, Independent Director
  • Robert S. Weiss, Independent Director
  • Dennis L. Winger, Independent Director

Who owns Accuray Incorporated stock?

Accuray Incorporated's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (8.11%), Neuberger Berman Group LLC (5.78%), Renaissance Technologies LLC (5.29%), Heartland Advisors Inc. (3.67%), Lapides Asset Management LLC (2.68%) and Boston Partners (2.24%). View Institutional Ownership Trends for Accuray Incorporated.

Who sold Accuray Incorporated stock? Who is selling Accuray Incorporated stock?

Accuray Incorporated's stock was sold by a variety of institutional investors in the last quarter, including Sectoral Asset Management Inc, Heartland Advisors Inc., Boston Partners, Neuberger Berman Group LLC, Wasatch Advisors Inc., Parametric Portfolio Associates LLC, New York State Common Retirement Fund and Bank of New York Mellon Corp. View Insider Buying and Selling for Accuray Incorporated.

Who bought Accuray Incorporated stock? Who is buying Accuray Incorporated stock?

Accuray Incorporated's stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Dimensional Fund Advisors LP, Spark Investment Management LLC, Teachers Advisors LLC, Global X Management Co. LLC, Royce & Associates LP, Russell Investments Group Ltd. and Renaissance Technologies LLC. View Insider Buying and Selling for Accuray Incorporated.

How do I buy Accuray Incorporated stock?

Shares of Accuray Incorporated can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Accuray Incorporated's stock price today?

One share of Accuray Incorporated stock can currently be purchased for approximately $4.50.


MarketBeat Community Rating for Accuray Incorporated (NASDAQ ARAY)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  176 (Vote Outperform)
Underperform Votes:  143 (Vote Underperform)
Total Votes:  319
MarketBeat's community ratings are surveys of what our community members think about Accuray Incorporated and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Accuray Incorporated (NASDAQ:ARAY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $6.00 (33.33% upside)

Analysts' Ratings History for Accuray Incorporated (NASDAQ:ARAY)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/24/2017BTIG ResearchReiterated RatingHoldMediumView Rating Details
8/24/2017Royal Bank Of CanadaReiterated RatingHold$5.00LowView Rating Details
8/23/2017Jefferies Group LLCLower Price TargetBuy$7.00 -> $6.00LowView Rating Details
3/21/2017AegisReiterated RatingBuyMediumView Rating Details
12/14/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$8.00 -> $6.00N/AView Rating Details
9/13/2016Cowen and CompanyInitiated CoverageOutperform$9.00N/AView Rating Details
8/18/2016Morgan StanleySet Price TargetHold$8.00N/AView Rating Details
5/22/2016Brean CapitalReiterated RatingBuy$12.00N/AView Rating Details
11/12/2015Citigroup Inc.Initiated CoverageSellN/AView Rating Details
(Data available from 9/26/2015 forward)

Earnings

Earnings History for Accuray Incorporated (NASDAQ:ARAY)
Earnings by Quarter for Accuray Incorporated (NASDAQ:ARAY)
Earnings History by Quarter for Accuray Incorporated (NASDAQ ARAY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2017($0.09)N/AView Earnings Details
8/22/20176/30/2017($0.01)($0.06)$112.00 million$112.09 millionViewN/AView Earnings Details
4/27/2017Q3 2017$0.01($0.06)$110.23 million$97.31 millionViewN/AView Earnings Details
1/31/2017Q217($0.09)($0.11)$93.74 million$87.50 millionViewListenView Earnings Details
10/27/2016Q117($0.10)($0.12)$37.34 million$86.50 millionViewListenView Earnings Details
8/17/2016Q316($0.07)($0.09)$98.97 million$95.00 millionViewListenView Earnings Details
4/26/2016Q316($0.06)$0.01$102.79 million$105.30 millionViewListenView Earnings Details
1/28/2016Q216($0.08)($0.08)$101.15 million$108.90 millionViewListenView Earnings Details
10/29/2015Q116($0.14)($0.12)$88.60 million$89.60 millionViewListenView Earnings Details
8/20/2015Q415($0.04)($0.07)$102.41 million$101.80 millionViewListenView Earnings Details
4/30/2015Q315($0.06)($0.04)$102.72 million$97.50 millionViewListenView Earnings Details
1/27/2015Q215($0.08)($0.13)$98.87 million$98.20 millionViewListenView Earnings Details
10/29/2014Q115($0.13)($0.28)$88.90 million$82.40 millionViewListenView Earnings Details
8/21/2014Q414($0.07)($0.13)$92.23 million$102.00 millionViewListenView Earnings Details
4/30/2014Q314($0.16)($0.06)$82.00 million$97.10 millionViewListenView Earnings Details
1/30/2014Q214($0.20)($0.07)$80.20 million$93.60 millionViewListenView Earnings Details
11/7/2013Q114($0.20)($0.21)$79.67 million$76.60 millionViewListenView Earnings Details
8/27/2013Q4 2013($0.20)($0.20)$82.29 million$84.90 millionViewListenView Earnings Details
5/7/2013Q3 2013($0.22)($0.37)$77.97 million$70.55 millionViewListenView Earnings Details
2/6/2013Q2 2013($0.33)($0.30)$74.23 million$77.80 millionViewListenView Earnings Details
11/7/2012Q113($0.22)($0.23)$85.41 million$83.00 millionViewN/AView Earnings Details
9/6/2012Q412($0.12)($0.20)$106.92 million$100.50 millionViewN/AView Earnings Details
5/8/2012($0.14)($0.21)ViewN/AView Earnings Details
11/8/2011($0.29)($0.38)ViewN/AView Earnings Details
9/19/2011$0.02($0.40)ViewN/AView Earnings Details
5/5/2011$0.04($0.02)ViewN/AView Earnings Details
1/27/2011($0.01)$0.07ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Accuray Incorporated (NASDAQ:ARAY)
2017 EPS Consensus Estimate: ($0.12)
2018 EPS Consensus Estimate: ($0.19)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.10)($0.10)($0.10)
Q2 20171($0.06)($0.06)($0.06)
Q3 20171$0.02$0.02$0.02
Q4 20171$0.02$0.02$0.02
Q1 20181($0.04)($0.04)($0.04)
Q2 20181($0.05)($0.05)($0.05)
Q3 20181($0.05)($0.05)($0.05)
Q4 20181($0.05)($0.05)($0.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Accuray Incorporated (NASDAQ:ARAY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Accuray Incorporated (NASDAQ:ARAY)
Insider Ownership Percentage: 2.91%
Institutional Ownership Percentage: 76.67%
Insider Trades by Quarter for Accuray Incorporated (NASDAQ:ARAY)
Institutional Ownership by Quarter for Accuray Incorporated (NASDAQ:ARAY)
Insider Trades by Quarter for Accuray Incorporated (NASDAQ:ARAY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/9/2015Joshua LevineCEOBuy50,000$7.12$356,000.00View SEC Filing  
2/2/2015Alaleh NouriSVPSell5,164$7.38$38,110.32View SEC Filing  
11/30/2014Alaleh NouriSVPSell268$6.62$1,774.16View SEC Filing  
11/30/2014Kelly LondyEVPSell2,273$6.62$15,047.26View SEC Filing  
11/3/2014Joshua LevineCEOBuy100,000$6.34$634,000.00View SEC Filing  
5/6/2014Joshua LevineCEOBuy50,000$8.15$407,500.00View SEC Filing  
2/4/2014Richard PettingillDirectorBuy9,795$10.33$101,182.35View SEC Filing  
12/4/2013Jack GoldsteinDirectorSell7,000$7.70$53,900.00View SEC Filing  
12/3/2013Elizabeth DavilaDirectorSell8,000$7.74$61,920.00View SEC Filing  
9/4/2013Darren J MillikenSVPSell11,002$6.53$71,843.06View SEC Filing  
3/5/2013Dennis L WingerDirectorBuy20,000$4.30$86,000.00View SEC Filing  
2/13/2013Joshua LevineCEOBuy100,000$4.38$438,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Accuray Incorporated (NASDAQ:ARAY)
Latest Headlines for Accuray Incorporated (NASDAQ:ARAY)
Source:
DateHeadline
nasdaq.com logoWhy Is Accuray (ARAY) Up 9.9% Since the Last Earnings Report? - Nasdaq
www.nasdaq.com - September 23 at 9:05 PM
finanznachrichten.de logoAccuray Showcases CyberKnife® and Radixact Systems at ASTRO 2017
www.finanznachrichten.de - September 22 at 6:30 PM
finance.yahoo.com logoWhy Is Accuray (ARAY) Up 9.9% Since the Last Earnings Report?
finance.yahoo.com - September 22 at 1:26 PM
finance.yahoo.com logoAccuray Showcases CyberKnife® and Radixact™ Systems at ASTRO 2017
finance.yahoo.com - September 20 at 4:44 PM
americanbankingnews.com logoAccuray Incorporated (ARAY) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - September 19 at 7:02 PM
finance.yahoo.com logoAccuray, Inc. breached its 50 day moving average in a Bullish Manner : ARAY-US : September 19, 2017
finance.yahoo.com - September 19 at 4:02 PM
americanbankingnews.com logo Analysts Anticipate Accuray Incorporated (ARAY) Will Announce Quarterly Sales of $89.18 Million
www.americanbankingnews.com - September 18 at 1:14 AM
americanbankingnews.com logoZacks: Analysts Anticipate Accuray Incorporated (ARAY) to Announce -$0.07 EPS
www.americanbankingnews.com - September 16 at 10:16 PM
americanbankingnews.com logoHead-To-Head Review: Varian Medical Systems (VAR) vs. Accuray (ARAY)
www.americanbankingnews.com - September 12 at 8:28 PM
finance.yahoo.com logoEarnings Review and Free Research Report: Accuray's Adjusted EBITDA Increased 108.9%
finance.yahoo.com - September 12 at 4:14 PM
finance.yahoo.com logoETFs with exposure to Accuray, Inc. : September 12, 2017
finance.yahoo.com - September 12 at 1:55 AM
finance.yahoo.com logoAccuray, Inc. :ARAY-US: Earnings Analysis: Q4, 2017 By the Numbers : September 5, 2017
finance.yahoo.com - September 5 at 5:36 PM
americanbankingnews.com logoAccuray Incorporated (ARAY) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - September 5 at 8:54 AM
finance.yahoo.com logoETFs with exposure to Accuray, Inc. : September 1, 2017
finance.yahoo.com - September 1 at 9:35 PM
finance.yahoo.com logoAccuray, Inc. :ARAY-US: Earnings Analysis: 2017 By the Numbers : August 29, 2017
finance.yahoo.com - August 29 at 4:19 PM
americanbankingnews.com logoZacks: Brokerages Expect Accuray Incorporated (ARAY) Will Post Earnings of -$0.07 Per Share
www.americanbankingnews.com - August 29 at 10:16 AM
americanbankingnews.com logoRoyal Bank Of Canada Reaffirms "Hold" Rating for Accuray Incorporated (ARAY)
www.americanbankingnews.com - August 28 at 6:14 PM
americanbankingnews.com logoFY2018 EPS Estimates for Accuray Incorporated Decreased by Analyst (ARAY)
www.americanbankingnews.com - August 25 at 1:20 PM
seekingalpha.com logoAccuray fiscal Q4 top line up 18%; non-GAAP EBITDA up 106%; gross orders down 10%
seekingalpha.com - August 24 at 4:03 PM
americanbankingnews.com logoAccuray Incorporated (ARAY) Receives "Hold" Rating from BTIG Research
www.americanbankingnews.com - August 24 at 1:18 PM
americanbankingnews.com logoJefferies Group Comments on Accuray Incorporated's Q1 2018 Earnings (ARAY)
www.americanbankingnews.com - August 24 at 8:46 AM
americanbankingnews.com logoJefferies Group LLC Cuts Accuray Incorporated (ARAY) Price Target to $6.00
www.americanbankingnews.com - August 23 at 7:10 PM
prnewswire.com logoAccuray Reports Fourth Quarter and Fiscal 2017 Financial Results - PR Newswire (press release)
www.prnewswire.com - August 23 at 8:31 AM
nasdaq.com logoAfter-Hours Earnings Report for August 22, 2017 : CRM, INTU, CREE, LZB, ARAY - Nasdaq
www.nasdaq.com - August 23 at 8:31 AM
finance.yahoo.com logoEdited Transcript of ARAY earnings conference call or presentation 22-Aug-17 8:30pm GMT
finance.yahoo.com - August 23 at 8:31 AM
americanbankingnews.com logoAccuray Incorporated (ARAY) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS
www.americanbankingnews.com - August 22 at 5:54 PM
rttnews.com logoEARNINGS SUMMARY: Details of Accuray Incorporated Q4 Earnings Report
www.rttnews.com - August 22 at 4:45 PM
finance.yahoo.com logoAccuray Reports Fourth Quarter and Fiscal 2017 Financial Results
finance.yahoo.com - August 22 at 4:45 PM
finance.yahoo.com logoAccuray reports 4Q loss
finance.yahoo.com - August 22 at 4:45 PM
finance.yahoo.com logoAccuray's Radixact Now Used by Boise Summit Cancer Center
finance.yahoo.com - August 18 at 4:06 PM
prnewswire.com logoSummit Cancer Center-Boise Treats Its First Cancer Patients Using the Accuray Radixact™ System - PR Newswire (press release)
www.prnewswire.com - August 17 at 10:27 PM
finance.yahoo.com logoSummit Cancer Center-Boise Treats Its First Cancer Patients Using the Accuray Radixact™ System
finance.yahoo.com - August 17 at 5:25 PM
americanbankingnews.com logoAccuray Incorporated (ARAY) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - August 15 at 1:10 AM
finance.yahoo.com logoAccuray To Report Fiscal 2017 Fourth Quarter And Full Year Results On August 22, 2017
finance.yahoo.com - August 14 at 4:23 PM
americanbankingnews.com logo$111.45 Million in Sales Expected for Accuray Incorporated (ARAY) This Quarter
www.americanbankingnews.com - August 12 at 1:46 AM
americanbankingnews.com logoAccuray Incorporated (NASDAQ:ARAY) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - August 11 at 8:42 AM
americanbankingnews.com logoAccuray Incorporated (NASDAQ:ARAY) Receives Buy Rating from Jefferies Group LLC
www.americanbankingnews.com - August 9 at 9:44 PM
prnewswire.com logoFirst Radixact™ System Research Results Presented at the ... - PR Newswire (press release)
www.prnewswire.com - August 4 at 4:20 PM
finance.yahoo.com logoFirst Radixact™ System Research Results Presented at the American Association of Physicists in Medicine Annual Meeting
finance.yahoo.com - August 4 at 4:20 PM
streetinsider.com logoAccuray (ARAY) Reports 510(k) Clearance for iDMS Data Management System Upgrade for TomoTherapy System
www.streetinsider.com - August 2 at 9:55 PM
streetinsider.com logoAccuray (ARAY) Reports 510(k) Clearance for iDMS Data Management System Upgrade for TomoTherapy System - StreetInsider.com
www.streetinsider.com - July 31 at 9:04 PM
finance.yahoo.com logoAccuray Receives 510(k) Clearance for iDMS™ Data Management System Upgrade for the TomoTherapy® System
finance.yahoo.com - July 31 at 4:02 PM
prnewswire.com logoAccuray Enhances Capital Structure Through Convertible Debt Transactions - PR Newswire (press release)
www.prnewswire.com - July 28 at 5:12 PM
finance.yahoo.com logoAccuray Enhances Capital Structure Through Convertible Debt Transactions
finance.yahoo.com - July 28 at 5:12 PM
nasdaq.com logoNew Strong Sell Stocks for July 24th - Nasdaq
www.nasdaq.com - July 24 at 1:05 PM
finance.yahoo.com logoNew Strong Sell Stocks for July 24th
finance.yahoo.com - July 24 at 1:05 PM
americanbankingnews.com logo Analysts Anticipate Accuray Incorporated (ARAY) Will Announce Quarterly Sales of $111.45 Million
www.americanbankingnews.com - July 23 at 8:28 AM
bizjournals.com logoMedical Equipment Stock Performance Review -- Amedica, Neovasc, Accuray, and NuVasive
www.bizjournals.com - July 21 at 5:02 PM
americanbankingnews.com logoAccuray Sees Unusually High Options Volume (NASDAQ:ARAY)
www.americanbankingnews.com - July 21 at 7:18 AM
streetinsider.com logoAccuray (ARAY) Presents New Data Showing TomoTherapy System ... - StreetInsider.com
www.streetinsider.com - July 20 at 5:22 PM

Social

Chart

Accuray Incorporated (ARAY) Chart for Tuesday, September, 26, 2017

This page was last updated on 9/26/2017 by MarketBeat.com Staff